GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Benchmark Holdings PLC (LSE:BMK) » Definitions » Debt-to-Revenue

Benchmark Holdings (LSE:BMK) Debt-to-Revenue : 0.61 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Benchmark Holdings Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Benchmark Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was £18.7 Mil. Benchmark Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was £80.0 Mil. Benchmark Holdings's annualized Revenue for the quarter that ended in Dec. 2023 was £161.9 Mil. Benchmark Holdings's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.61.


Benchmark Holdings Debt-to-Revenue Historical Data

The historical data trend for Benchmark Holdings's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benchmark Holdings Debt-to-Revenue Chart

Benchmark Holdings Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.83 1.03 0.96 0.70 0.60

Benchmark Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.59 0.73 0.70 0.61

Competitive Comparison of Benchmark Holdings's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Benchmark Holdings's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Benchmark Holdings's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Benchmark Holdings's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Benchmark Holdings's Debt-to-Revenue falls into.



Benchmark Holdings Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Benchmark Holdings's Debt-to-Revenue for the fiscal year that ended in Sep. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(20.045 + 81.954) / 169.476
=0.60

Benchmark Holdings's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(18.682 + 80.032) / 161.892
=0.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.


Benchmark Holdings Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Benchmark Holdings's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Benchmark Holdings (LSE:BMK) Business Description

Traded in Other Exchanges
Address
Yeoman Way, Highdown House, Worthing, West Sussex, GBR, BN99 3HH
Benchmark Holdings PLC is engaged in the healthcare sector. Its operating segment includes Genetics; Advanced Nutrition; Health; and Corporate. The company generates maximum revenue from the Advanced Nutrition segment. The Advanced Nutrition segment manufactures and provides technically advanced nutrition and health products to the aquaculture industry. Geographically, it derives a majority of its revenue from Norway and also has a presence in Vietnam; the Faroe Islands; Ecuador; India; Greece; Canada; Chile, and the Rest of World.

Benchmark Holdings (LSE:BMK) Headlines

No Headlines